Anidulafungin interactions

Full monograph for Anidulafungin Check it against another medicine

Medicines

1 documented

Severity

Medicines documented to interact with Anidulafungin, worst severity first.
Medicine	Severity	Mechanism	Effect	Sources
Cyclosporine (Oral)	Minor	Others	Coadministration with cyclosporine may modestly increase the plasma concentrations of anidulafungin. The mechanism has not been described. A separate in vitro…	14 sources — open the full entry

Conditions

Conditions in which Anidulafungin needs care, as documented in this source.

Liver Diseases
Moderate
Laboratory abnormalities in liver function tests have been observed in healthy volunteers and patients treated with echinocandins, and clinical hepatic abnormalities have occurred in some patients with serious underlying conditions who were receiving multiple concomitant medications with echinocandin therapy. Isolated cases of significant hepatic dysfunction, hepatitis, or worsening hepatic failure have also been reported, although a causal relationship has not been established. Therapy with echinocandins should be administered cautiously in patients with preexisting liver disease. Liver function should be monitored regularly during therapy.
3 sources
1. "Product Information. Cancidas (caspofungin)." Merck & Co., Inc (2001):
2. "Product Information. Mycamine (micafungin)." Fujisawa (2005):
3. "Product Information. Eraxis (anidulafungin)." Pfizer U.S. Pharmaceuticals Group (2006):